FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W61054095> ?p ?o ?g. }

• W61054095 endingPage "440" @default.
• W61054095 startingPage "427" @default.
• W61054095 abstract "Four cyclic-nucleotide phosphodiesterase (PDE) genes belonging to the PDE4 family (PDE4A, 4B, 4C and 4D) have been identified. All four isogenes, including several deletions and alterations of the amino, carboxyl and central catalytic domains, were expressed in insect cells. Lysates were characterised for enzyme activity by using the Km for substrate and the EC50 for activation by the cofactor Mg2+. The catalytic domain alone appears to be sufficient for the normal enzymatic function of PDE4 proteins. Substrate affinity varied by less than 2-fold between catalytic-domain forms of the PDE4A, 4B and 4D isogenes and the long forms (PDE4A5, PDE4B1 and PDE4D3). The affinity for Mg2+ varied by less than 4-fold between long and catalytic-domain forms of PDE4A and 4B. The catalytic-domain form of PDE4D, however, had a 12-fold lower affinity for Mg2+ that was restored by including a portion of the amino-terminal domain, upstream conserved region-2 (UCR2). This result suggests that the Mg2+-binding site of PDE4D involves the UCR2 region. Inhibition of the PDE4 proteins by synthetic compounds is apparently affected differently by the domains. For PDE4B, the catalytic domain is sufficient for interactions with the inhibitors studied: IBMX, trequinsin, rolipram, TVX 2706, RP 73401 and RS-25344. For PDE4D the catalytic-domain form is less sensitive than the long form to inhibition by RS-25344, rolipram and TVX 2706, by 1463-, 11-and 12-fold, respectively. Addition of UCR2 to the catalytic-domain form of PDE4D restored all the lost sensitivities. The catalytic-domain form of PDE4A showed a reduced inhibitor affinity with RS-25344 and TVX 2706 by 77- and 90-fold, respectively. Both catalytic-domain and long forms of PDE4 isogenes interacted with equal affinity with the non-specific inhibitors IBMX and trequinsin, as well as the very potent PDE4-specific inhibitor RP 73401. Other potent and specific PDE4 inhibitors, such as rolipram, RS-25344 or TVX 2706, appear to utilize non-catalytic domain interactions with PDE4D and 4A to supplement those within the catalytic domains. These observations suggest a different relation between amino and catalytic domains in PDE4D relative to PDE4B. We therefore propose a model to illustrate these isogene-specific PDE4 domain interactions with substrate, inhibitors and the co-factor Mg2+. The model for PDE4D is also discussed in relation to changes in the activation curve for Mg2+ and sensitivity to RS-25344 that accompany phosphorylation of the long form by protein kinase A." @default.
• W61054095 created "2016-06-24" @default.
• W61054095 creator A5020049725 @default.
• W61054095 creator A5020824672 @default.
• W61054095 creator A5022112843 @default.
• W61054095 creator A5025211706 @default.
• W61054095 creator A5026529363 @default.
• W61054095 creator A5029695887 @default.
• W61054095 creator A5031421595 @default.
• W61054095 creator A5033768956 @default.
• W61054095 creator A5055302959 @default.
• W61054095 creator A5066251436 @default.
• W61054095 creator A5079344893 @default.
• W61054095 creator A5087945720 @default.
• W61054095 date "1998-06-01" @default.
• W61054095 modified "2023-09-23" @default.
• W61054095 title "Comparison of Recombinant Human PDE4 Isoforms" @default.
• W61054095 cites W1489466981 @default.
• W61054095 cites W1510098440 @default.
• W61054095 cites W1529224585 @default.
• W61054095 cites W174001001 @default.
• W61054095 cites W1800918825 @default.
• W61054095 cites W1827795204 @default.
• W61054095 cites W1973613293 @default.
• W61054095 cites W1977177612 @default.
• W61054095 cites W1993259491 @default.
• W61054095 cites W2003843533 @default.
• W61054095 cites W2003922574 @default.
• W61054095 cites W2014465746 @default.
• W61054095 cites W2028496153 @default.
• W61054095 cites W2048497209 @default.
• W61054095 cites W2056976451 @default.
• W61054095 cites W2058280387 @default.
• W61054095 cites W2058281805 @default.
• W61054095 cites W2059232755 @default.
• W61054095 cites W2062616704 @default.
• W61054095 cites W2068124617 @default.
• W61054095 cites W2075499154 @default.
• W61054095 cites W2092052750 @default.
• W61054095 cites W2106753244 @default.
• W61054095 cites W2130381329 @default.
• W61054095 cites W2133137629 @default.
• W61054095 cites W2164744404 @default.
• W61054095 cites W2279019749 @default.
• W61054095 cites W2341184974 @default.
• W61054095 cites W2341366090 @default.
• W61054095 cites W2488106867 @default.
• W61054095 cites W4254104742 @default.
• W61054095 doi "https://doi.org/10.1016/s0898-6568(97)00169-1" @default.
• W61054095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9720765" @default.
• W61054095 hasPublicationYear "1998" @default.
• W61054095 type Work @default.
• W61054095 sameAs 61054095 @default.
• W61054095 citedByCount "50" @default.
• W61054095 countsByYear W610540952012 @default.
• W61054095 countsByYear W610540952013 @default.
• W61054095 countsByYear W610540952014 @default.
• W61054095 countsByYear W610540952015 @default.
• W61054095 countsByYear W610540952016 @default.
• W61054095 countsByYear W610540952017 @default.
• W61054095 countsByYear W610540952019 @default.
• W61054095 countsByYear W610540952020 @default.
• W61054095 countsByYear W610540952021 @default.
• W61054095 countsByYear W610540952022 @default.
• W61054095 countsByYear W610540952023 @default.
• W61054095 crossrefType "journal-article" @default.
• W61054095 hasAuthorship W61054095A5020049725 @default.
• W61054095 hasAuthorship W61054095A5020824672 @default.
• W61054095 hasAuthorship W61054095A5022112843 @default.
• W61054095 hasAuthorship W61054095A5025211706 @default.
• W61054095 hasAuthorship W61054095A5026529363 @default.
• W61054095 hasAuthorship W61054095A5029695887 @default.
• W61054095 hasAuthorship W61054095A5031421595 @default.
• W61054095 hasAuthorship W61054095A5033768956 @default.
• W61054095 hasAuthorship W61054095A5055302959 @default.
• W61054095 hasAuthorship W61054095A5066251436 @default.
• W61054095 hasAuthorship W61054095A5079344893 @default.
• W61054095 hasAuthorship W61054095A5087945720 @default.
• W61054095 hasConcept C181199279 @default.
• W61054095 hasConcept C185592680 @default.
• W61054095 hasConcept C202751555 @default.
• W61054095 hasConcept C2776958096 @default.
• W61054095 hasConcept C2779276759 @default.
• W61054095 hasConcept C2781298581 @default.
• W61054095 hasConcept C55493867 @default.
• W61054095 hasConcept C62826618 @default.
• W61054095 hasConcept C71240020 @default.
• W61054095 hasConceptScore W61054095C181199279 @default.
• W61054095 hasConceptScore W61054095C185592680 @default.
• W61054095 hasConceptScore W61054095C202751555 @default.
• W61054095 hasConceptScore W61054095C2776958096 @default.
• W61054095 hasConceptScore W61054095C2779276759 @default.
• W61054095 hasConceptScore W61054095C2781298581 @default.
• W61054095 hasConceptScore W61054095C55493867 @default.
• W61054095 hasConceptScore W61054095C62826618 @default.
• W61054095 hasConceptScore W61054095C71240020 @default.
• W61054095 hasIssue "6" @default.
• W61054095 hasLocation W610540951 @default.

• next